SCHEMBL7709830

SCHEMBL7709830

Bc1ccc2[nH]c(=O)sc2c1

nearest known ligand 0.60

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE3B Q13370 3/20 0.55
PDE3A Q14432 3/20 0.55
PGR P06401 2/20 0.49
CMA1 P23946 1/20 0.48
ALDH1A1 P00352 2/20 0.42
PKM P14618 1/20 0.42
KIF11 P52732 1/20 0.42
POLB P06746 1/20 0.42
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.39
MKNK1 Q9BUB5 1/20 0.38
GRIA1 P42261 1/20 0.38
CACNG8 Q8WXS5 1/20 0.38
HTR1A P08908 1/20 0.38
HTR2C P28335 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SYK P43405 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29895649 0.75 PDE3B (0.55) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL6190639 0.75 POLB (0.56) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL29186754 0.75 PDE3B (0.55) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL20106905 0.75 PDE3B (0.55) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL1848968 0.75 PDE3B (0.55) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL6190902 0.75 CMA1 (0.75) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL489133 0.75 PDE3B (0.55) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL435577 0.75 PDE3B (0.59) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL118581 0.75 PDE3B (0.55) PDE3BPDE3APGRCMA1ALDH1A1
SCHEMBL14940358 0.72 PDE3B (0.51) PDE3BPDE3APGRCMA1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011137046-A1 SUBSTITUTED 1,3-BENZOTHIAZOL-2(3H)-ONES AND [1,3]THIAZOLO[5,4-B]PYRIDIN-2(1H)-ONES AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 MERCK SHARP & DOHME CORP. (US) 2011-11-03 WO disclosed
WO-2008132139-A2 NEW HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS UCB PHARMA S.A. (BE) 2008-11-06 WO disclosed
WO-2008132142-A2 NEW HETEROCYCLIC DERIVATIVES USEFUL FOR THE TREATMENT OF CNS DISORDERS UCB PHARMA S.A. (BE) 2008-11-06 WO disclosed